CYYNF (Cynata Therapeutics) FCF Yield %: -298.16 (As of Jun. 26, 2026)


What is Cynata Therapeutics FCF Yield %?

Cynata Therapeutics CYYNF -95.96% FCF Yield % is -298.16 as of Jun. 26, 2026. The stock has 1 warning sign investors should review. Among 1,418 Biotechnology companies, Cynata Therapeutics ranks worse than 96.47% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cynata Therapeutics's Trailing 12-Month Free Cash Flow is $-5.36 Mil, and Market Cap is $2.02 Mil. Therefore, Cynata Therapeutics's FCF Yield % for today is -298.16%.

The historical rank and industry rank for Cynata Therapeutics's FCF Yield % or its related term are showing as below:

CYYNF' s FCF Yield % Range Over the Past 10 Years
Min: -298.16   Med: 0   Max: 0
Current: -298.16

CYYNF's FCF Yield % is ranked worse than
96.47% of 1418 companies
in the Biotechnology industry
Industry Median: -9.715 vs CYYNF: -298.16

Cynata Therapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

Cynata Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Cynata Therapeutics FCF Yield % Related Terms

Cynata Therapeutics FCF Yield % Historical Data

* Premium members only.

The historical data trend for Cynata Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cynata Therapeutics FCF Yield % Chart

Cynata Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.92 -5.39 -22.24 -19.38 -31.59

Cynata Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.23 -19.88 -8.80 -41.75 -8.90

CYYNF vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Cynata Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cynata Therapeutics FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cynata Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cynata Therapeutics's FCF Yield % falls into.


Cynata Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cynata Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-5.71 / 18.07632
=-31.59%

Cynata Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.585 * 2 / 35.6181
=-8.90%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -298.16 mean?
Cynata Therapeutics (CYYNF) has a FCF Yield % of -298.16 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cynata Therapeutics and its competitors. According to the industry distribution chart, Cynata Therapeutics ranks #1368 out of 1418 companies in the Biotechnology industry, placing it in the top 96.5%.
Is Cynata Therapeutics' FCF Yield % too high?
Cynata Therapeutics' current FCF Yield % is -298.16. Based on the distribution chart, Cynata Therapeutics ranks #1368 out of 1418 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Cynata Therapeutics' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Cynata Therapeutics ranks #1368 out of 1418 companies for FCF Yield %. This places Cynata Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Cynata Therapeutics and its competitors. Cynata Therapeutics's current FCF Yield % is -298.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cynata Therapeutics stock overvalued right now?
Cynata Therapeutics (CYYNF) has a current FCF Yield % of -298.16. The current FCF Yield % is -298.16. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Cynata Therapeutics (CYYNF), the current FCF Yield % is -298.16 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cynata Therapeutics Business Description

Other Exchanges 51S:GermanyCYP:Australia
Address 100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus manufacturing platform. There are currently three active clinical trials taking place using Cymerus technology, which are attempting to treat osteoarthritis and others.